What Does a Positive Cologuard Mean?

A positive Cologuard result means the test detected abnormal DNA markers, blood, or both in your stool sample, but it does not mean you have colorectal cancer. In one community-based study, only about 4% of people who went on to get a colonoscopy after a positive Cologuard actually had cancer, while roughly three-quarters had no cancer and no advanced precancerous growths at all. The result is a flag that says “something worth investigating turned up,” and the single most important thing to do next is schedule a follow-up colonoscopy so a doctor can look directly at the lining of your colon.

What Cologuard Is Actually Detecting

Cologuard is a multitarget stool DNA test, often abbreviated mt-sDNA. Instead of relying on a single signal, it looks for several things at once: altered DNA shed by abnormal cells in the colon lining and traces of blood that you would never notice on your own. Colorectal cancers and precancerous polyps tend to release cells with specific genetic changes into the stool, and the test is designed to pick those up. It also includes a component similar to the fecal immunochemical test (FIT) that checks for hidden blood. Because it combines these approaches, the stool DNA test has higher sensitivity than FIT alone, though it costs considerably more as a screening tool.¹

The trade-off for that higher sensitivity is a higher false-positive rate. The test casts a wide net on purpose: it is better to flag someone who turns out to be fine than to miss a cancer. That is why a positive result lands so many people in the “nothing found on colonoscopy” category. The test did exactly what it was designed to do; it just erred on the side of caution.

What a Follow-Up Colonoscopy Typically Finds

If you are staring at a positive Cologuard result, the number you probably want most is this: what are the actual odds that something serious is going on? A study that tracked community patients who tested positive and then completed a diagnostic colonoscopy broke the findings into three buckets. About 4% had colorectal cancer. Roughly 24% had advanced adenomas, which are larger or more concerning precancerous polyps that usually get removed during the procedure. And about 73% had neither cancer nor advanced growths.²

That last group is the largest by far, and it includes people with small, non-advanced polyps as well as people with completely normal colons. For them, the positive Cologuard was a false alarm. It can feel frustrating to go through the prep and the procedure for what turns out to be nothing, but the colonoscopy itself is not wasted: it effectively resets the clock on your screening, and having a clean scope is genuinely reassuring in a way a stool test alone cannot be.

For the roughly one in four people with advanced adenomas, the colonoscopy does double duty. The gastroenterologist can usually remove those polyps on the spot, preventing them from ever developing into cancer. This is where the screening pipeline delivers real value. Without the positive Cologuard, those polyps might have sat there growing for years before causing symptoms.

Why Some People Never Get the Colonoscopy

A positive result only helps you if you follow through with the diagnostic colonoscopy, and a surprising number of people do not. One study found that only 44% of patients who tested positive completed a follow-up colonoscopy within 12 months.³ A separate study focused on younger adults aged 45 to 49 found much higher follow-up rates among mt-sDNA users, with about 85% completing a colonoscopy, compared to roughly 35% of those who had been screened with FIT. The median time to colonoscopy after a positive mt-sDNA test was 53 days.⁴

Follow-up rates also vary by income and insurance type. A national study of women found that 71% completed a colonoscopy within a year of a positive mt-sDNA test, but the numbers ranged from about 67% among those in lower-income areas to over 83% among those in the highest-income bracket. Women on traditional Medicare had the highest completion rate at nearly 79%, while those on Medicaid had the lowest at about 65%.⁵

These gaps are not just about laziness or forgetfulness. A scoping review of barriers to diagnostic colonoscopy after a positive stool test identified a pattern of obstacles at every level: personal fear and anxiety, a sense that “I feel fine so it’s probably nothing,” weak follow-up from the ordering provider, scheduling and referral failures within the healthcare system, transportation difficulties, and out-of-pocket costs or insurance coverage gaps.⁶ If you have gotten a positive result and feel tempted to put off the colonoscopy, you are not alone, but the data strongly argues against waiting. The whole point of the screening test was to get you to this step.

The Insurance Wrinkle You Should Know About

One of the most common and unpleasant surprises after a positive Cologuard is the bill. Under the Affordable Care Act, the initial stool-based screening test is typically covered with no out-of-pocket cost as preventive care. But once that test comes back positive, the follow-up colonoscopy is often reclassified as a “diagnostic” procedure rather than a “screening” one. That distinction matters because diagnostic colonoscopies can trigger deductibles, copays, and coinsurance that screening colonoscopies would not.

This reclassification catches many people off guard. The cost-sharing gap was specifically identified as one of the recurring policy-level barriers that prevent people from completing follow-up colonoscopies after a positive stool test.⁶ Legislative efforts in several states have tried to close this loophole by requiring insurers to cover follow-up colonoscopies at the same zero-cost level as initial screenings, and a federal fix has been discussed. But coverage depends on where you live and what plan you carry. Before your procedure, call your insurance company and ask specifically whether a diagnostic colonoscopy after a positive stool screening test will be covered as preventive, and get the answer in writing if you can.

The Emotional Side of a Positive Result

Reading “positive” on any cancer-related test can trigger a wave of anxiety, even if you intellectually understand that most positive stool tests do not mean cancer. Qualitative research on people who received false-positive results on colorectal cancer screening found that some participants described being so frightened they felt like they had “already died” in their minds. Others said they were not worried at all because they felt healthy, but even those individuals reported feeling noticeably relieved and even celebratory when their colonoscopy came back clean, suggesting the anxiety was there under the surface.⁷

Family members often bear some of the emotional weight too. In interviews, several people noted that their close relatives were visibly shaken even when they themselves claimed to feel calm. The anxiety around the colonoscopy procedure itself, separate from any worry about the results, was another common theme. The prep, the sedation, even the physical setting of the endoscopy suite made some people more nervous than the possibility of cancer did.

A population-based study measuring psychological distress found that people who tested positive on a stool-based screening test scored higher on anxiety and worry immediately afterward, but those elevated scores returned to normal within about 12 months regardless of whether cancer was found.⁸ For most people, the distress is real but temporary. However, some individuals reported recurring spikes of anxiety long afterward, triggered by noticing changes in their stool or encountering anything related to cancer screening. If you find the anxiety lingering, that is worth mentioning to your doctor.

The Quality of the Colonoscopist Matters

Not all colonoscopies are created equal, and this is especially relevant when you are getting one because of an abnormal stool test. Gastroenterologists are tracked on quality metrics like adenoma detection rate (ADR), which is the percentage of screening colonoscopies in which they find at least one adenoma. A higher ADR generally means a more thorough examiner.

A study using data from the New Hampshire Colonoscopy Registry found that endoscopists in the highest quality quartile detected adenomas in about 63% of colonoscopies performed after a positive mt-sDNA test. They also found significantly fewer “negative” (nothing found) colonoscopies compared to endoscopists in lower quality tiers. Endoscopists with the highest detection rates for a specific type of polyp called sessile serrated lesions found them in about 29% of post-Cologuard colonoscopies, versus much lower rates among less-skilled examiners.⁹

What this means practically is that some of the “false positives” attributed to Cologuard may actually be cases where a less thorough colonoscopist missed a real lesion. If you have a choice of providers, asking about their adenoma detection rate is a reasonable and increasingly common question. Many gastroenterology practices will share this metric if asked.

What Happens If the Colonoscopy Cannot Be Completed

Sometimes a colonoscopy does not go as planned. The scope cannot always reach the beginning of the colon, especially in patients with prior abdominal surgery, severe diverticular disease, or a particularly tortuous colon. When this happens after a positive Cologuard, it is important not to leave that territory unexamined, because the test flagged something and you still need an answer.

European guidelines recommend CT colonography, a specialized CT scan of the colon, preferably the same day or the next day after an incomplete colonoscopy.¹⁰ The timing matters because the bowel prep you suffered through is still in effect, so the scan can be done without a second round of prep. A study evaluating CT colonography after incomplete colonoscopies found that it revealed relevant additional findings, both inside and outside the colon, in about 19% of patients. In cases where colorectal cancer was detected this way, the scan also doubled as a staging tool to gauge how far the cancer had spread.¹¹ If your colonoscopy was cut short and nobody has mentioned a backup imaging plan, bring it up yourself.

Cologuard’s Place Among Screening Options

Cologuard is not the only way to screen for colorectal cancer, and it is worth understanding where it sits relative to the alternatives. The three main options for average-risk adults are colonoscopy (typically every 10 years), FIT (annually), and Cologuard (every 3 years). Each has trade-offs.

Colonoscopy is the gold standard for finding and removing polyps, but it requires sedation, bowel prep, a day off work, and carries a small risk of complications like perforation or bleeding. FIT is cheap, easy, and done annually, but it is less sensitive for precancerous lesions. Cologuard sits in the middle: more sensitive than FIT, done less frequently, but more expensive and with a higher false-positive rate that leads to more diagnostic colonoscopies.

Cost-effectiveness modeling paints a nuanced picture. One analysis found that at about $600 per test with a 3-year screening interval, Cologuard provided reasonable performance at an acceptable cost compared to no screening.¹² But a head-to-head comparison found that when everyone follows through perfectly, yearly FIT and colonoscopy every 10 years were both more effective and less expensive than Cologuard every 3 years. The case for Cologuard improved mainly in scenarios where people were more likely to actually complete it than they were to stick with annual FIT testing.¹³

That last point is the real-world argument for Cologuard. The best screening test is the one you actually do. If you know you will not stick with an annual FIT, and you are not willing to go straight to colonoscopy, a stool DNA test every three years is vastly better than skipping screening entirely. But if you have gotten a positive result, the irony is that you are now headed for a colonoscopy anyway, which is the test you may have been trying to avoid.

When a Positive Cologuard Keeps Coming Back

A scenario that confuses patients and even some clinicians is what to do when Cologuard comes back positive, the follow-up colonoscopy is clean, and then a subsequent Cologuard is positive again. Guidelines are clear that another positive stool test should not be ignored simply because the last colonoscopy was normal. Current recommendations call for another colonoscopy, because the test may be picking up something that was missed or has developed since the last scope.

This is where the quality of the original colonoscopy really matters. If the first endoscopist had a lower detection rate, a repeat positive Cologuard may be catching a lesion that was overlooked. If a high-quality colonoscopy was truly clean, a repeat positive is more likely another false alarm, but the standard of care is still to scope again rather than assume.

Some patients in this cycle understandably wonder whether Cologuard is the right screening tool for them going forward. If you are someone whose biology produces repeated false positives, your doctor may recommend switching to colonoscopy on a regular schedule or to annual FIT, which has a lower false-positive rate. There is no rule that says you must keep using the same screening method, and a conversation with your gastroenterologist about which approach fits your situation is the right next step after a frustrating repeat experience.

Screening in Younger Adults

Colorectal cancer screening guidelines expanded in 2021 to recommend that average-risk adults begin at age 45 instead of 50. This change was driven by a rising incidence of colorectal cancer in younger people, and it brought a new population into Cologuard’s orbit. Data on younger adults aged 45 to 49 suggest that follow-up colonoscopy adherence after a positive mt-sDNA test is strong in this group, with about 85% completing the procedure, and more than 60% doing so within 90 days.⁴

Younger adults tend to have a lower baseline prevalence of colorectal cancer and advanced adenomas, which means the positive predictive value of any screening test is lower in this age group. In plain terms, a positive Cologuard in a 46-year-old is even less likely to mean cancer than the same result in a 68-year-old. That can feel like you went through the whole process for nothing, but detecting even a small adenoma in your mid-forties gives you decades of lead time to monitor and manage your colon health. The emotional weight of a positive result at a younger age can also be heavier simply because cancer screening feels like something that “happens to older people,” and the psychological effects described earlier may hit differently when you were not expecting to deal with this at all.